Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transplant recipients: A preliminary experience
10.1097/01.TP.0000054682.53834.EA
Saved in:
Main Authors: | Aw, M.M., Taylor, R.M., Verma, A., Parke, A., Baker, A.J., Hadzic, D., Muiesan, P., Rela, M., Heaton, N.D., Mieli-Vergani, G., Dhawan, A. |
---|---|
Other Authors: | PAEDIATRICS |
Format: | Conference or Workshop Item |
Published: |
2013
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/48032 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Long-term outcome of mycophenolate mofetil rescue therapy for resistant acute allograft rejection in pediatric liver transplant recipients
by: Aw, M.M., et al.
Published: (2011) -
Treatment of steroid-resistant acute liver transplant rejection with Basiliximab
by: Fernandes, M.L., et al.
Published: (2011) -
Delayed tacrolimus is safe with basiliximab induction therapy
by: Lee, K.H., et al.
Published: (2016) -
Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: A 5-year follow-up
by: Aw, M.M., et al.
Published: (2014) -
Low-dose OKT3 is not effective in the treatment of steroid-resistant acute renal allograft rejections
by: Lye, WC, et al.
Published: (2022)